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Abstract
Calorie	 restriction	 (CR),	 an	 age	 delaying	 diet,	 affects	 fat	 oxidation	 through	 poorly	
understood	mechanisms.	We	investigated	the	effect	of	CR	on	fat	metabolism	gene	
expression	and	intermediate	metabolites	of	fatty	acid	oxidation	in	the	liver.	We	found	
that CR changed the liver acylcarnitine profile: acetylcarnitine, short-chain acylcar-
nitines,	 and	 long-chain	 3-hydroxy-acylcarnitines	 increased,	 and	 several	 long-chain	
acylcarnitines decreased. Acetyl-CoA and short-chain acyl-CoAs were also increased 
in	CR.	CR	did	not	affect	the	expression	of	CPT1	and	upregulated	the	expression	of	
long-chain and very-long-chain Acyl-CoA dehydrogenases (LCAD and VLCAD, re-
spectively).	The	expression	of	downstream	enzymes	such	as	mitochondrial	 trifunc-
tional	protein	and	enzymes	in	medium-	and	short-chain	acyl-CoAs	oxidation	was	not	
affected	in	CR.	CR	shifted	the	balance	of	fatty	acid	oxidation	enzymes	and	fatty	acid	
metabolites	 in	the	 liver.	Acetyl-CoA	generated	through	beta-oxidation	can	be	used	
for ketogenesis or energy production. In agreement, blood ketone bodies increased 
under	CR	in	a	time	of	the	day-dependent	manner.	Carnitine	acetyltransferase	(CrAT)	
is a bidirectional enzyme that interconverts short-chain acyl-CoAs and their cor-
responding	acylcarnitines.	CrAT	expression	was	 induced	 in	CR	 liver	supporting	the	
increased acetylcarnitine and short-chain acylcarnitine production. Acetylcarnitine 
can	freely	travel	between	cellular	sub-compartments.	Supporting	this	CR	increased	
protein	acetylation	in	the	mitochondria,	cytoplasm,	and	nucleus.	We	hypothesize	that	
changes in acyl-CoA and acylcarnitine levels help to control energy metabolism and 
contribute	to	metabolic	flexibility	under	CR.
K E Y W O R D S
aging,	circadian	rhythms,	diet,	fat,	gene	expression,	metabolism
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1  |  INTRODUC TION
Increased incidence of metabolic diseases is a significant challenge 
for modern society. Metabolic syndrome contributes to the devel-
opment of diabetes, cardiovascular diseases, and cancer (Bonomini 
et	 al.,	 2015;	Muoio,	 2014).	 Disruption	 in	 lipid	 homeostasis	 is	 one	
of	the	hallmarks	of	metabolic	and	age	related	diseases	(Johnson	&	
Stolzing,	2019;	Savage	et	al.,	2007).	Diet	is	recognized	as	an	import-
ant factor affecting disease development and progression. Caloric 
restriction	(CR),	a	reduction	 in	food	intake	without	malnutrition,	 is	
one of the dietary interventions known to have a universally positive 
effect on metabolism in animal models and humans (Longo et al., 
2015).	Multiple	 cellular	 and	 physiological	 systems	 are	 affected	 by	
CR, and some of these changes may contribute to CR-induced met-
abolic	 health	 benefits.	 Shift	 in	 energy	metabolism	 is	 a	 recognized	
metabolic adaptation to limited nutrient resources available under 
CR	(Anderson	&	Weindruch,	2010).	Judged	by	respiratory	exchange	
ratio,	AL	 fed	 rodents	predominantly	oxidize	carbohydrates	around	
the clock, in contrast with that, CR animals change substrate pref-
erence	through	the	day:	First	few	hours	after	the	meal,	they	oxidize	
carbohydrates;	 then,	 they	 gradually	 switch	 to	 fatty	 acid	 oxidation	
until	the	next	meal	(Bruss	et	al.,	2010).	The	shift	 in	energy	metab-
olism may be linked with changes in the feeding pattern of CR an-
imals. AL fed animals eat around the clock. CR animals, which are 
usually fed once per day at the same time, consume the entire meal 
in	 roughly	 2	 h	 and	 fast	 for	 the	 next	 21–23	 h.	 (Acosta-Rodríguez	
et	al.,	2017;	Bruss	et	al.,	2010;	Patel	et	al.,	2016;	Velingkaar	et	al.,	
2020).	Changes	in	fat	metabolism	under	CR	have	been	reported	in	
Drosophila	suggesting	a	conservative	response	(Katewa	et	al.,	2016).
Fatty	 acids	 are	 oxidized	 through	 a	 chain	 of	 reactions	 that	 re-
quire	coordinated	activity	of	several	enzymes,	which	expression	and	
activity in the liver and other tissues are affected by dietary inter-
ventions	(Barger	et	al.,	2015;	Eckel-Mahan	et	al.,	2013;	Kuhla	et	al.,	
2014).	Little	 is	known	 if	 the	expression	of	 fatty	acid	oxidation	en-
zymes	is	affected	in	CR.	Protein	expression	has	not	been	reported	
in	CR,	and	there	are	several	transcriptomic	studies	with	mixed	out-
comes	 (reviewed	 in	 (Swindell,	 2009).	 Discrepancy	 of	 results	 from	
different reports may be due to different times of feeding for the 
experiment	 and	 analysis	 of	 RNA.	 The	 feeding/oxidation	 cycle	 has	
24-h	periodicity,	which	implies	a	possible	interaction	with	circadian	
rhythms, and this is supported by evidence of a crosstalk between 
aging,	CR,	and	the	circadian	clock	(Makwana	et	al.,	2019;	Patel	et	al.,	
2016;	Sato	et	al.,	2017).	Therefore,	the	circadian	rhythms	must	be	
taken into consideration to understand CR-induced reprogramming 
of fat metabolism.
It	is	hypothesized	that	fat	oxidation	is	increased	in	CR	(Anderson	
&	Weindruch,	2010),	and	the	shift	 in	preference	for	substrate	oxi-
dation	 is	 in	 line	with	this	hypothesis	 (Bruss	et	al.,	2010).	However,	
molecular	 events	 associated	 with	 fat	 oxidation	 in	 CR	 tissues	 are	
mostly unknown. Acylcarnitines are intermediate metabolites in 
beta-oxidation,	and	analysis	of	tissue	and	blood	levels	of	acylcarni-
tines	is	a	widely	accepted	method	for	evaluating	fatty	acid	oxidation	
(El-Gharbawy	&	Vockley,	2018;	Rinaldo	et	al.,	2008).	Acylcarnitine	
profiling has not been performed in mice on CR across the day. Here, 
we	compared	acyl-CoAs,	acylcarnitines,	and	the	expression	of	fatty	
acid metabolism enzymes across the day in the liver of mice on AL 
and	CR	diets.	We	found	that	some	acylcarnitines	oscillated	during	
the day suggesting their production may be regulated by diet and the 
clock.	CR	 increased	 expression	 of	 several	 fat	 catabolism	 enzymes	
such	as	carnitine	palmitoyl	transferase	2	(CPT2),	VLCAD,	and	LCAD,	
while CPTI and many downstream enzymes such as mitochondrial 
trifunctional	protein	(MTP),	medium-chain	acyl-CoA	dehydrogenase	
(MCAD),	 short-chain	 acyl-CoA	 dehydrogenase	 (SCAD),	 and	 ace-
tyl-CoA	acyl	transferase	2	(ACAA2)	were	not	affected.	Surprisingly,	
levels	of	short-chain	acyl-CoAs	(acetyl-CoA,	C4-CoA	and	C6-CoA)	
and corresponding acylcarnitines were significantly increased in 
the CR liver. Accumulation of energy rich short-chain acyl-CoAs, 
especially acetyl-CoA, under limited resources of CR diet was coun-
terintuitive and suggests that they may play additional roles in the 
mechanisms	of	CR.	We	hypothesize	that	changes	in	fatty	acid	oxi-
dation and production of acetyl-CoA/acetylcarnitine pools coordi-
nate metabolic processes in the liver and may contribute to health 
benefits of CR.
2  |  RESULTS
2.1  |  CR affected liver acylcarnitine profiles
To	study	 the	effect	of	diet	on	 fatty	acid	oxidation,	CR	was	 imple-
mented	 to	 3-month	 old	 C57B6/J	 mice.	 CR	mice	 received	 70%	 of	
AL	food	intake	to	achieve	30%	CR	for	2	months.	CR	mice	received	
F I G U R E  1 CR	increased	short-chain	acylcarnitines	in	the	liver.	(a)	Fold	changes	in	daily	average	level	of	short-chain	(left	panel),	medium-
chain	(middle	panel),	and	long-chain	(right	panel)	acylcarnitines	in	CR	liver	(n	=	24	per	diet).	Daily	average	of	acylcarnitines	in	AL	liver	were	
set as one, shown as dashed line. Acylcarnitine species are annotated as following [number of carbon atoms]:[number of double bonds]. 
(b)	Daily	rhythms	of	several	acylcarnitines	in	the	liver	of	AL	(blue	diamonds)	and	CR	(red	circles)	mice	(data	represented	as	average±STD,	
n	=	4	per	time	point	per	diet).	(c)	Relative	changes	in	free	and	total	carnitine	and	ratio	of	free	to	total	carnitine	in	AL	(blue)	and	CR	(red).	
(d)	Daily	rhythms	of	free	carnitine	(data	represented	as	average±STD,	n	=	4	per	time	point	per	diet).	(e)	Phase	distribution	of	rhythmic	
acylcarnitines,	AL	(blue)	and	CR	(red).	(f)	Daily	rhythms	in	the	expression	of	circadian	clock	genes	Bmal1, Per2, and Per1 (data represented 
as	average±STD,	n	=	3	per	time	point	per	diet).	(g)	Daily	rhythms	in	ribosomal	protein	S6	phosphorylation	and	(h)	representative	Western	
blot	and	quantification	(data	represented	as	average±STD,	n	=	3	per	time	point	per	diet).	*—statistically	significant	difference,	p	<	0.05,	by	
t	test.	#—statistically	significant	effect	of	diet,	p	<	0.05,	two-way	ANOVA.	Shadowed	area	on	the	graphs	or	dark	bar	above	the	Western	
blot	represents	dark	phase	of	the	day,	the	light	was	on	at	ZT0,	and	the	light	was	off	at	ZT12.	Table	S1	contains	statistics	from	ANOVA	and	
student's t	test	for	acylcarnitines.	Tables	S2	and	S3	contain	statistics	for	24-h	and	12-h	rhythm	analysis	for	acylcarnitines,	respectively
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food	at	ZT14,	2	h	 after	 the	 light	 is	 turned	off,	which	 corresponds	
to	 the	 regular	 feeding	 time	 for	AL	mice.	As	expected,	CR	resulted	
in significantly reduced body weight: Average body weight was 
30.6	±	2.6	g	for	AL	mice	and	25.4	±	1.9	g	for	CR	mice.	Blood	glucose	
was	also	significantly	reduced:	173.4	±	11.5	mg/dl	for	AL	mice	and	
116.9	±	13.1	mg/dl	 for	CR	mice.	After	 two	months	of	CR,	 tissues	
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were	harvested	for	the	analysis	of	gene	expression	and	intermedi-
ate	metabolites	 in	 fatty	 acid	 oxidation	 such	 as	 acylcarnitines	 and	
acyl-CoA. Fat metabolism is known to be affected by time of feed-
ing	 and	 by	 the	 circadian	 clock	 (Adamovich	 et	 al.,	 2015;	 Loizides-
Mangold	et	al.,	2017).	Therefore,	acylcarnitines	were	analyzed	at	6	
time	points	around	the	clock.	We	assayed	acylcarnitines	in	the	liver	
of	AL	and	CR	mice	using	LC-MS/MS.	CR	has	 two	main	effects	on	
acylcarnitine profiles. First, CR significantly affected the level of 
acylcarnitines, daily averages for short-, medium-, and long-chain 
acylcarnitines	are	shown	in	Figure	1a	(relative	change)	and	in	Figure	
S1	(absolute	values).	Short-chain	acylcarnitines:	acetylcarnitine,	bu-
tyrylcarnitine,	and	hexanoylcarnitine	were	significantly	upregulated	
by CR. Daily average levels of acetylcarnitine and butyrylcarnitine 
were	 induced	 by	 more	 than	 tenfolds,	 and	 hexanoylcarnitine	 was	
induced	 by	 about	 3-folds.	 Medium-chain	 (C8-C12)	 acylcarnitines	
were	not	significantly	affected	with	an	exception	for	2-fold	 induc-
tion for C12-acylcarnitine. The effect of CR on long-chain acylcar-
nitine	(C14–C20)	was	not	uniform.	C14	acylcarnitines	were	induced	
by about 2 times, and C16:2 was slightly induced. C16, C16:1, C18, 
and C18:1 acylcarnitines were not significantly affected. Finally, 
C18:2-acylcarnitines	and	C20:4	acylcarnitines	were	reduced	by	CR.	
CR	also	resulted	in	70%	increase	in	free	carnitine	and	3-fold	increase	
in	total	liver	carnitines	(Figure	1c).	Thus,	CR	liver	either	increased	the	
synthesis	or	the	uptake	of	free	carnitine.	Interestingly,	only	28%	of	
cellular	carnitine	was	free	in	CR	contrary	to	50%	of	free	carnitine	in	
AL	liver	(Figure	1c).
The second major effect of CR was on acylcarnitine daily rhythms. 
Daily profiles of absolute values for several acylcarnitines are shown 
in	 Figure	 1b	 and	 Figure	 S2A.	 While	 many	 acylcarnitines	 demon-
strated significant changes throughout the day, only a few of them 
demonstrated	circadian	rhythms	(Table	S2).	Figure	1e	shows	around	
the clock phase distribution for rhythmic acylcarnitines. AL mice eat 
around the clock, and they have two major meals, one meal is around 
ZT12–ZT16	and	another	meal	around	ZT20–ZT2	(Velingkaar	et	al.,	
2020).	We	analyzed	if	some	acylcarnitines	oscillated	with	a	12-h	pe-
riod.	Indeed,	9	acylcarnitines	demonstrated	12-h	rhythms	in	AL	liver	
with	peaks	around	the	beginning	(ZT0)	and	end	(ZT12)	of	the	light	
period	(Table	S3	and	Figure	S2B).	Under	CR,	only	three	long-chain	
acylcarnitines	were	rhythmic	with	a	12-h	period	(Table	S3	and	Figure	
S2B).	Free	carnitine	followed	12-h	rhythms	in	AL	and	24-h	rhythms	
in	CR	liver	(Figure	1d,e	and	Figure	S2B).	Thus,	changes	in	period	of	
acylcarnitine oscillation agreed with changes in food intake pattern.
Circadian clock is implicated in the control of fatty acid metab-
olism	 (Adamovich	et	 al.,	 2015;	 Loizides-Mangold	et	 al.,	 2017).	We	
assayed	rhythms	 in	mRNA	for	circadian	clock	genes.	As	 it	was	ex-
pected,	 the	expression	of	Bmal1, Per1, and Per2 genes was rhyth-
mic	under	both	diets	and	rhythms	were	enhanced	by	CR	(Figure	1f).	
Phases	of	clock	gene	expression	were	not	significantly	affected	by	
CR.	We	also	assayed	phosphorylation	of	ribosomal	S6	protein	as	a	
surrogate marker of mTORC1 activity. In agreement with previous 
reports	 (Tulsian	 et	 al.,	 2018),	 S6	 phosphorylation	oscillates	 during	
the	day	in	the	liver	on	both	diets	(Figure	1g,h).	The	peak	of	S6	phos-
phorylation	was	between	ZT14	and	ZT18	for	both	diets.	Further	in-
vestigation is required to determine whether the observed changes 
in acylcarnitine rhythms are linked with changes in the circadian 
clock or mTOR signaling rhythms.
2.2  |  CR-induced expression of long-chain fatty 
acid beta-oxidation enzymes in mitochondria
Accumulation of acetylcarnitine is an indication of increased fatty 
acid	 oxidation,	which	 agrees	with	 previously	 reported	 increases	
in	whole	body	 fat	oxidation	under	CR	 (Bruss	et	 al.,	 2010).	Beta-
oxidation	occurs	 in	mitochondria	 and	peroxisomes.	The	chain	of	
biochemical reactions is similar between these two organelles, 
but	the	enzymes	involved	in	the	process	are	different	(Figure	2a).	
We	 monitored	 the	 expression	 of	 enzymes	 responsible	 for	 fatty	
acid	 activation,	 transport	 to	 mitochondria	 and	 oxidation	 in	 the	
liver	by	Western	blotting.	The	expression	of	long-chain	acyl-CoA	
synthetase	3	 (ACSL3)	was	slightly	 induced	by	CR	 (Figure	2b	and	
Figure	 S3).	 Surprisingly,	 CR	 did	 not	 affected	 the	 expression	 of	
F I G U R E  2 CR	resulted	in	increased	oxidation	of	long-chain	fatty	acids	in	mitochondria.	(a)	Scheme	of	fatty	acid	beta-oxidation	in	
mitochondria	and	peroxisomes.	Adipose	tissue	originated	long-chain	fatty	acids	(C14-C20)	are	activated	to	long-chain	Acyl-CoAs	and	
oxidized	through	cyclic	reaction	cascade	in	mitochondria	or	peroxisomes.	Enzymes	controlling	corresponding	steps	in	beta-oxidation	are	
shown	in	the	same	color.	The	first	step	of	mitochondrial	beta-oxidation	is	catalyzed	by	four	enzymes	from	the	Acyl-CoA	Dehydrogenase	
(ACAD)	family.	These	enzymes	have	substrate	preferences:	very-long-chain	ACAD	C14-20,	long-chain	ACAD	(C10–C16),	medium-chain	
ACAD	(C6–C10),	and	short-chain	ACAD	(C4–C6).	Long-chain	acyl-CoAs	are	oxidized	first	through	the	reactions	controlled	by	VLCAD	
and	LCAD,	resulting	in	chain	shortening	for	subsequent	oxidation	by	MCAD	and,	finally,	by	SCAD.	See	further	details	in	the	text.	(b)	
Representative	Western	blotting	of	beta-oxidation	enzymes	in	the	liver	of	AL	(marked	as	a)	and	CR	(marked	as	c)	mice,	across	the	day.	Every	
line represents pooled samples (n	=	3).	Light	and	dark	bars	represent	light	and	dark	phases	of	the	day.	(c)	Protein	and	(d)	mRNA	expression,	
from	left	to	right:	first	panels—VLCAD	protein	and	corresponding	Acadvl	gene;	second	panels—LCAD	protein	and	corresponding	Acadl 
gene;	(c)	third	panel—ACOT3/4	protein,	and	(d)	third	panel	Acot4 and fourth panel Acot3	genes	(data	represented	as	average±STD,	n = 3 per 
time	point	per	diet).	(e)	Examples	of	daily	rhythms	of	short-chain	(C6)	and	long	(C14	and	C18)	hydroxy-acylcarnitines	in	the	liver	of	AL	(blue	
lines)	and	CR	(red	lines)	mice	(data	represented	as	average±STD,	n	=	4	per	time	point	per	diet).	(f)	Fold	change	in	ratio	between	hydroxy-
acylcarnitines	and	corresponding	acylcarnitines	in	CR	liver.	The	ratio	between	hydroxy-acylcarnitine	and	corresponding	acylcarnitine	was	
set as one for AL (n	=	24	per	diet).	Acylcarnitine	species	are	annotated	as	following	[number	of	carbon	atoms]:[number	of	double	bonds].	*—
statistically significant difference, p	<	0.05	t	test.	#—statistically	significant	effect	of	diet,	p	<	0.05,	two-way	ANOVA.	Shadowed	area	on	the	
graphs	or	dark	bar	above	the	Western	blot	represents	dark	phase	of	the	day,	the	light	was	on	at	ZT0,	and	the	light	was	off	at	ZT12.	Tables	
S4,	S5,	and	S6	contain	statistics	from	anova	and	student's	t	test	for	qPCR,	Western	blot,	and	hydroxy-acylcarnitine	results,	respectively
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F I G U R E  3 CR	increased	short-chain	acyl-CoAs	in	the	liver	and	blood	ketone	bodies.	(a)	Daily	rhythms	of	several	acyl-CoAs	in	the	liver	of	
AL	(blue	diamonds)	and	CR	(red	circles)	mice	(data	represented	as	average±STD,	n	=	4	per	time	point	per	diet).	(b)	Daily	rhythms	of	free	CoA	
in	the	liver	of	AL	(blue	diamonds)	and	CR	(red	circles)	mice	(data	represented	as	average±STD,	n	=	4	per	time	point	per	diet).	(c)	Daily	rhythms	
of	total	CoA	in	the	liver	of	AL	(blue	diamonds)	and	CR	(red	circles)	mice	(data	represented	as	average±STD,	n	=	4	per	time	point	per	diet).	(d)	
Ratio	between	free	and	total	CoAs	in	the	liver	of	AL	(blue	bar)	and	CR	(red	bar)	mice;	n	=	24	per	diet.	(e)	Daily	rhythms	of	malonyl-CoA	in	
the	liver	of	AL	(blue	diamonds)	and	CR	(red	circles)	mice	(data	represented	as	average±STD,	n	=	4	per	time	point	per	diet).	(f)	Representative	
Western	blotting	in	the	liver	of	AL	(marked	as	a)	and	CR	(marked	as	c)	mice,	across	the	day.	Every	line	represents	pooled	samples	(n	=	3).	
(G)	Daily	rhythms	of	expression	of	CPT2	(left	panel)	and	CrAT	(right	panel)	in	the	liver	of	AL	(blue	diamonds)	and	CR	(red	circles)	mice	(data	
represented	as	average±STD,	n	=	3	per	time	point	per	diet).	(h)	Ketone	bodies	(beta-hydroxybutyrate)	in	the	blood	(data	represented	as	
average±STD)	of	AL	(n	=	6)	(blue	bars),	and	CR	(n	=	8)	(red	bars)	at	ZT14	and	ZT18.	(i)	mRNA	expression	for	Crat gene (data represented 
as	average±STD,	n	=	3	per	time	point	per	diet).	Light	and	dark	bars	represent	light	and	dark	phases	of	the	day.	*—statistically	significant	
difference, p	<	0.05,	t	test.	#—statistically	significant	effect	of	diet,	p	<	0.05,	two-way	ANOVA.	Shadowed	area	on	the	graphs	or	dark	bar	
above	the	Western	blot	represents	dark	phase	of	the	day,	the	light	was	on	at	ZT0,	and	the	light	was	off	at	ZT12.	Table	S7	contains	statistics	
from	ANOVA	and	student's	t test for acyl-CoAs
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CPT1	(Figure	2b	and	Figure	S3),	which	is	considered	as	one	of	the	
key	enzymes	in	mitochondria	fat	oxidation	(Eaton,	2002).	CPT1	ac-
tivity is also regulated by malonyl-CoA, but malonyl-CoA level was 
not	affected	by	CR	(Figure	3e).	CR	induced	the	expression	of	both	
VLCAD	and	LCAD	at	multiple	times	around	the	clock	(Figure	2b,c).	
The	expression	of	HADHB,	a	 subunit	of	MTP,	 that	catalyzes	 the	
last	step	of	long-chain	acyl-CoA	oxidation	was	not	significantly	af-
fected.	The	expression	of	MCAD	was	slightly,	but	not	significantly,	
upregulated,	and	the	expression	of	SCAD	was	not	affected	by	CR.	
The	 expression	 of	 HADHSC	 and	 ACAA2	 that	 catalyze	 the	 next	
steps	in	oxidation	of	medium-	and	short-chain	acyl-CoA	was	also	
not	significantly	affected	by	CR.	(Figure	2b).	Thus,	the	effect	of	CR	
on	 fatty	acid	metabolic	enzyme	expression	was	 selective,	which	
changed the balance between different enzymes and contributed 
to the differential acylcarnitine profile.
Peroxisomes	 are	 another	 site	 for	 beta-oxidation	 (Figure	 2a)	
(Fransen	 et	 al.,	 2017).	ACOX1	 is	 a	 peroxisomal	 dehydrogenase	 and	
functional analog of ACADs, where it catalyzes the first step of acyl-
CoA	beta-oxidation.	 In	contrast	with	mitochondrial	dehydrogenases,	
CR	did	not	increase	ACOX1	expression	and	even	slightly	down	regu-
lated	the	expression	(Figure	2b).	The	expression	of	peroxisomal	thio-
esterases	ACOT3	and/or	ACOT4	(the	antibodies	cannot	distinct	these	
two	highly	homologous	enzymes)	was	increased	under	CR.	ACOTs	in-
activate	acyl-CoAs	by	removing	the	CoA	group	(Tillander	et	al.,	2017).	
Thus,	 the	 expression	 of	 the	 first	 committed	 enzyme	 in	 peroxisomal	
beta-oxidation	was	downregulated,	and	the	expression	of	inactivation	
enzymes	were	increased	by	CR.	We	concluded	that	it	is	unlikely	that	
peroxisomal	oxidation	of	 fatty	acids	was	significantly	 induced	under	
CR, and the majority of increased acylcarnitines are generated in the 
mitochondria.	 Peroxisomal	 beta-oxidation	 is	 not	 coupled	 with	 ATP	
production;	 instead,	hydrogen	peroxide	and	heat	are	generated.	 It	 is	
not	a	surprise	that	with	limited	resources	under	CR,	peroxisomal	be-
ta-oxidation	is	not	induced.
To understand the mechanisms of CR-induced changes in be-
ta-oxidation	 enzymes,	 the	 mRNA	 expression	 for	 their	 genes	 was	
assayed.	The	expression	of	Acadvl	(encodes	VLCAD),	Acadl (encodes 
LCAD),	and	peroxisomal	Acot3 and Acot4 was significantly induced 
by	CR	 in	 a	 time	of	 the	day-dependent	manner	 (Figure	2d).	mRNA	
expression	was	in	agreement	with	protein	expression	and	with	pub-
lished	data	on	polysome	association	 (Makwana	et	al.,	2019).	Thus,	
the	changes	in	mRNA	expression	might	provide	a	mechanistic	expla-
nation	for	increased	protein	expression.
2.3  |  CR increased accumulation of long-chain 
3-hydroxy-acylcarnitines
3-hydroxy-acyl-CoAs	 are	 intermediates	of	beta-oxidation	 (Su	et	 al.,	
2005).	 Corresponding	 acylcarnitines	 are	 formed	 by	 CPT2	 (Ramsay,	
2000).	Several	3-hydroxy-acylcarnitines	were	detected	in	the	liver	of	
AL	and	CR	mice.	Daily	profiles	of	3-hydroxy-hexanoylcarnitine	 (C6-
OH),	3-hydroxy-myristoylcarnitine	(C14-OH),	and	3-hydroxy-octade-
cenoyl	(C18:1-OH)	are	shown	in	Figure	2e,	while	others	are	shown	in	
Figure	S4A.	Most	of	the	detected	3-hydroxy-acylcarnitines	demon-
strated changes through the day in both diets, several of them were 
rhythmic	with	24-h	or	12-h	periods	 (Figure	S4B	and	Tables	S2	and	
S3).	Daily	 average	 levels	 of	 3-hydroxy-acylcarnitines	 are	 presented	
in	Figure	S5.	There	was	a	statistically	significant	 increase	 in	several	
long-chain	 3-hydroxy-acylcarnitines	 (C14-OH,	 C14:1-OH,	 C18-OH,	
and	C18:1-OH),	and	C16:1-OH	demonstrated	a	tendency	to	increase	
(Figure	 S5C).	 All	 detected	 medium-chain	 3-hydroxy-acylcarnitines	
(C8:1-OH,	C10-OH,	C12-OH,	and	C12:1-OH)	were	modestly	induced	
by	CR	(Figure	S5B).	3-hydroxy-hexanoylcarnitine	was	reduced	by	CR	
in	a	time	of	the	day-dependent	manner	 (Figure	S5A	and	Figure	2e).	
3-hydroxybutyrylcarnitine	was	induced,	but	the	induction	was	not	as	
strong	as	the	induction	in	butyrylcarnitine	(Figure	S5A	and	Figure	1a).	
To	calculate	the	ratio	between	3-hydroxy-acylcarnitine	and	acylcarni-
tine,	the	concentration	of	3-hydroxy-acylcarnitine	in	the	sample	was	
divided on the concentration of cognate acylcarnitine in the same 
sample.	 The	 calculated	 ratio	 across	 the	 day	 is	 shown	 in	 Figure	 S6.	
Figure	2f	represents	the	fold	change	for	the	ratio	between	hydroxy-
acylcarnitine and their cognate acylcarnitine (the ratio was set up as 
1,	shown	as	dotted	line,	for	every	acylcarnitine	in	AL).	CR	resulted	in	
several fold increase for long-chain carnitines (C16:1, C18, C18:1 and 
C18:2)	and	a	couple	medium-chain	carnitines	(C10	and	C8:1)	and	sev-
eral	fold	decrease	for	short-chain	carnitines	(C4	and	C6).	Thus,	liver	
3-hydroxy-acylcarnitines	were	not	accumulated	in	proportion	to	their	
cognate acylcarnitine, which further supports significant changes in 
fatty	acid	oxidation	induced	by	CR.
2.4  |  CR increases accumulation of short-chain 
acyl-CoA
Acylcarnitines are in dynamic balance with their cognate acyl-CoAs 
(Brass	&	Hoppel,	1980).	The	increased	concentration	of	short-chain	
acylcarnitines is an indication of increased levels of associated acyl-
CoAs.	We	 directly	 assayed	 levels	 of	 several	 short	 acyl-CoAs	 and	
long-chain palmitoyl-CoA in the liver. In agreement with acylcar-
nitine data CR resulted in significant upregulation of acetyl-CoA, 
butyryl-CoA,	 and	 hexanoyl-CoA	 at	 all	 six	 time	 points	 across	 the	
day	(Figure	3a).	Free	(Figure	3b)	and	total	(Figure	3c)	CoAs	were	in-
creased by several folds in CR liver suggesting either increased pro-
duction or reduced degradation of CoA. Interestingly, free and total 
CoAs were significantly affected by CR but there was no significant 
difference	in	free	to	total	ratio	between	the	diets	(Figure	3d).
The conversion between acyl-CoAs and acylcarnitines in the 
mitochondria is regulated by two mitochondrial carnitine acyltrans-
ferases: CPT2 and CrAT. CPT2 acts on long-chain and medium-chain 
acyl-CoAs	 (Kerner	&	Hoppel,	2000),	and	CrAT	acts	on	short-chain	
and	 medium-chain	 acyl-CoAs	 including	 acetyl-CoA	 (Seiler	 et	 al.,	
2015).	 The	 expression	 of	 both	 enzymes	 was	 significantly	 upreg-
ulated	by	CR	 (Figure	3f,g).	Crat	mRNA	expression	was	also	signifi-
cantly	 upregulated	 in	CR	 liver	 (Figure	3i).	Cytoplasmic	 short-chain	
acyl-CoA	synthases	(ACSS2)	convert	acetate	to	acetyl-CoA,	and	the	
expression	of	ACSS2	was	not	significantly	affected	by	CR	(Figure	3f).	
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We	also	calculated	the	ratio	between	acylcarnitines	and	acyl-CoA.	
The	 results	 are	presented	 in	Figure	S7.	 Interestingly,	 the	 ratio	be-
tween acyl-CoA and cognate acylcarnitine was changed across the 
day for both diets and the profiles were different for different acyls. 
These results suggest that reversible interconversion between acyl-
CoAs and acylcarnitines was not in equilibrium. The changes in CrAT 
and	CPT2	expression	might	contribute	to	this	dynamic	balance.
2.5  |  CR affected blood ketone bodies
Acetyl-CoA is a precursor for several biochemical reactions, and it 
can	serve	as	a	signaling	molecule	(Pietrocola	et	al.,	2015).	High	levels	
of acetyl-CoA are frequently associated with increased fat biosyn-
thesis. Malonyl-CoA is a rate-limiting precursor for fatty acid bio-
synthesis and regulator of CPT1 activity. The level of malonyl-CoA 
F I G U R E  4 Caloric	restriction	affected	protein	acetylation	in	the	liver.	(a)	Representative	Western	blotting	of	protein	acetylation	in	total	
lysates	from	the	liver	of	AL	(marked	as	a)	and	CR	(marked	as	c)	mice.	(b)	Quantification	of	several	major	bands	from	(a),	upper	panel—band	I,	
middle	panel—band	II,	lower	panel—band	III.	(c)	Western	blotting	of	cytoplasmic	(left),	nuclear	(middle),	and	mitochondrial	(right)	fractions	of	
the	liver,	tissues	were	collected	at	ZT14.	Cellular	fraction	separation	was	confirmed	by	Western	blotting	for	GAPDH	(cytoplasm),	Histone	H3	
(nucleus),	and	VDAC1	(mitochondrial).	(d)	Effect	of	CR	on	acyl-CoA	metabolism	(model).	After	activation	and	transport	to	mitochondria	long-
chain	fatty	acids	are	oxidized	by	mitochondrial	membrane	associated	VLCAD	and	VCAD,	which	expression	is	increased	under	CR.	As	a	result,	
short-chain acyl-CoAs are accumulated in the CR liver. Mitochondrial acyl-CoAs and acylcarnitines are in a dynamic equilibrium controlled 
by	CPT2	and	CrAT,	which	expression	is	increased	by	CR.	Short-chain	acylcarnitines	can	travel	from	mitochondria	to	cytoplasm,	where	they	
can be converted back to acyl-CoAs. Elevated acetyl-CoA can be used for ketone body production and for regulation of metabolism, either 
through	the	direct	suppression	of	PDH	and	activation	of	PC	or	through	protein	acetylation.	Short-chain	acylcarnitines	may	also	travel	into	
the	bloodstream	to	be	used	by	other	tissues	for	energy	production.	Components	with	red	text	are	upregulated	under	CR
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was	 not	 increased	 and	 even	 reduced	 in	 the	 CR	 liver	 (Figure	 3e),	
which	was	not	surprising.	Synthesis	of	fatty	acids	from	acetyl-CoA	
that	were	produced	as	 a	 result	of	 fatty	 acid	oxidation	would	be	a	
futile cycle. Acetyl-CoA is a precursor for ketone body production 
(Pietrocola	 et	 al.,	 2015).	 Blood	 ketones	were	 assayed	 at	 two	 time	
points	at	ZT14	(before	feeding	CR	mice)	and	at	ZT18	(4	h	after	feed-
ing	CR	mice).	Blood	ketone	bodies	were	low	at	both	time	points	in	
AL	mice	(Figure	3h).	In	CR	mice,	blood	ketone	bodies	were	several	
folds	higher	compared	with	AL	at	ZT14,	and	they	were	as	low	as	AL	
at ZT18. Interestingly, acetyl-CoA levels were several folds higher in 
the CR liver compared with AL at both time points; thus, increased 
acetyl-CoA contributed to the increased blood ketones in CR, but 
additional	regulations	also	exist.
2.6  |  CR increased protein acetylation in the liver
Acetyl-CoA is a cofactor for protein acetylation, and increased level 
of acetyl-CoA correlates with increased protein acetylation. It was 
previously reported that CR increases protein acetylation in mito-
chondrial	(Schwer	et	al.,	2009)	and	total	(Sato	et	al.,	2017)	liver	ex-
tracts. Protein acetylation in the liver was measured with antibodies 
to	acetyl-lysine	(Figure	4a).	Intensity	of	multiple	bands	was	increased	
several	 folds	 in	CR	 liver	across	 the	day.	Quantitative	data	 for	sev-
eral	bands	are	shown	in	Figure	4b.	To	determine	whether	increased	
protein	acetylation	is	exclusively	in	the	mitochondria,	liver	extracts	
were	fractionated	(Figure	4c).	The	quality	of	fraction	separation	was	
confirmed with known markers histone H3 for the nucleus, GAPDH 
for the cytoplasm and VDAC1 for the mitochondria. Protein acetyla-
tion was measured in cytoplasmic, nuclear, and mitochondrial frac-
tions	separately	at	one	time	point	of	the	day	(ZT14).	The	increase	in	
acetylation was evident in all fractions. Interestingly, the increase in 
acetylation	was	not	absolute;	for	example,	there	was	no	increase	in	
the	 intensity	of	17-kDa	band	 in	nuclear	 fractions.	Protein	acetyla-
tion can be catalyzed by protein acetylases, or it can be enzyme-
independent	(Pietrocola	et	al.,	2015),	and	an	increase	in	acetyl-CoA	
shall stimulate both. At the same time, protein deacetylases have 
substrate preferences, and observed differences in acetylation pat-
tern might be due to the regulatory change of protein deacetylase 
activity, which warrants further study.
2.7  |  CR differentially affected expression of 
PPARα transcriptional targets
PPARα is a transcriptional factor and master regulator of liver fat 
metabolism	(Kersten	et	al.,	1999).	 It	was	hypothesized	that	PPARα 
activity	might	 be	 induced	 by	CR	 (Masternak	&	Bartke,	 2007),	 but	
it	 was	 never	 directly	 demonstrated.	 Several	 of	 the	 upregulated	
fat	oxidation	enzymes	are	known	targets	of	PPARα; therefore, we 
decided to investigate whether several other PPARα targets were 
affected	in	CR	liver.	The	expression	for	all	assayed	PPARα transcrip-
tional targets was significantly affected in CR liver (Figure 2d, 3i and 
Figure	 S8).	Acadl, Acadvl, Crat, Hadhb, Slc25a20, Acot3, and Acot4 
were significantly induced at several time points. Acadm and Cpt2 
were induced only at one time point. Diet had a significant effect 
on Acads, Cpt1a, and Hmgcs2	expression,	but	the	difference	did	not	
reach significance at any time point (see details of statistical analysis 
in	Table	S4).	A	ketogenic	diet	is	a	popular	dietary	intervention	to	im-
prove metabolism, and there are some parallels between CR and ke-
togenic diet. Recently, an analysis of the liver transcriptome around 
the clock in mice on ketogenic diet concluded that PPARα transcrip-
tional	activity	is	induced	by	ketogenic	diet	(Tognini	et	al.,	2017).	We	
analyzed	available	RNAseq	data	from	Tognini	et	al	and	compared	it	
with	 the	 expression	 in	 our	 study.	 The	 expression	 of	 these	 PPARα 
targets is strongly upregulated by ketogenic diet at all time points 
around the clock, which is in contrast with CR that have a time of the 
day-dependent effect and overall minimal induction (Tognini et al., 
2017).	Protein	expression	was	not	reported;	therefore,	it	is	unclear	
if	ketogenic	diet	induced	mRNA	expression	will	translate	to	the	pro-
tein level. Thus, CR and ketogenic diet have significantly different 
effects	on	the	expression	of	fat	oxidation	enzymes	and	PPARα tran-
scriptional targets.
3  |  DISCUSSION
Fatty	acid	beta-oxidation	is	the	main	mechanism	of	energy	produc-
tion	under	CR,	and	a	strong	flux	of	fatty	acids	to	the	liver	is	expected	
under	CR	(Anderson	&	Weindruch,	2010;	Bruss	et	al.,	2010).	Profiling	
of acylcarnitines is a widely accepted method to detect changes in 
fatty	acid	oxidation	(El-Gharbawy	&	Vockley,	2018).	We	performed	
a	comprehensive	circadian	analysis	of	acylcarnitines	and	unexpect-
edly found a selective effect of CR on acylcarnitine and acyl-CoA 
rhythms in the liver. Acetylcarnitine and acetyl-CoA levels were pre-
viously	assayed	in	CR	with	mixed	results.	Acetylcarnitine	is	elevated	
by	acute	CR	in	human	serum	(Collet	et	al.,	2017),	which	agrees	with	
our data. At the same time, reduced acetyl-CoA was observed by 
(Hebert	et	al.,	2013)	and	(Perry	et	al.,	2018).	Finally,	Gopalan	et	al	re-
ported no significant effect on acetylcarnitine levels (Gopalan et al., 
2016).	We	do	not	know	what	exactly	causes	the	difference	between	
our study and cited studies: Hebert et al performed analysis only in 
one	sample,	Perry	et	al	used	a	diabetic	rat	model	and	severe	4-day	
CR, Gopalan et al used high-fat diet induced obesity rat model and 
CR that was implemented with high-fat diet. Methods of acetyl-CoA 
analysis were different between studies. Data on protein acetylation 
under	CR	from	our	study	and	two	other	studies	 (Sato	et	al.,	2017;	
Schwer	et	al.,	2009)	are	in	line	with	the	increase	in	acetyl-CoA	in	CR	
liver. Gopalan et al also reported an induction for a few long-chain 
acylcarnitines;	however,	 the	effect	was	significant	for	15%	CR	but	
not	30%	CR	 (Gopalan	et	al.,	2016).	To	 the	best	of	our	knowledge,	
the effect of CR on acylcarnitine profile in healthy animals has not 
been reported.
The	expression	of	several	fat	oxidation	genes	is	affected	by	CR	
according	 to	 several	 transcriptomic	 studies	 (Swindell,	2009),	but	
protein	expression	was	not	reported.	The	expression	of	CPT1	and	
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its physiological regulator malonyl-CoA were not significantly af-
fected	by	CR.	CR	significantly	increased	the	expression	of	VLCAD	
and LCAD, which are enzymes involved in the initial steps of fatty 
acid	beta-oxidation,	but	did	not	increase	the	expression	of	down-
stream enzymes such as trifunctional protein subunits or any of 
the	enzymes	involved	in	medium	and	short-chain	beta-oxidation.	
These results are in contrast with the effect of ketogenic diet 
which	results	 in	significant	upregulation	of	mRNAs	for	all	fat	ox-
idation	enzymes	 (Tognini	et	al.,	2017).	Of	note,	only	mRNA	data	
are available from Tognini et al, and the effect of ketogenic diet on 
protein	 expression	was	 not	 reported.	CR	 and	 ketogenic	 induced	
changes in acylcarnitine profiles were also different. Medium and 
long-chain, but not short-chain acylcarnitines, accumulate in the 
liver	of	mice	after	4	days	on	ketogenic	diet	(Lee	et	al.,	2016).	Thus,	
CR and ketogenic diet differently reprogram fat metabolism. CR 
did	not	simply	increase	fat	oxidation;	rather,	the	balance	between	
upstream and downstream enzymes was significantly shifted, 
which in turn might contribute to the observed changes in the 
acylcarnitine profile.
We	 also	 compared	 the	 acylcarnitine	 profiles	 in	 CR	 liver	 with	
acylcarnitine profiles in tissues and body fluids from other studies 
using	animal	models	and	clinical	cases	of	fatty	acid	oxidation	defi-
ciency.	 SCAD	 deficient	 mice	 have	 increased	 hexanoylcarnitine	 in	
the liver, but butyrylcarnitine and acetylcarnitine are not increased, 
and medium and long-chain acylcarnitines, which are upstream in 
beta-oxidation	pathways,	are	also	significantly	upregulated	(Ghosh	
et	al.,	2016).	MCAD	deficient	mice	have	increased	accumulation	of	
C6-C10 acylcarnitines and no increase in short-chain acylcarnitines 
(Tolwani	 et	 al.,	 2005).	 LCAD	 deficient	mice	 have	 almost	 opposite	
acylcarnitine profile to the profile of CR: increased long-chain acyl-
carnitines,	 reduced	 level	 of	 3-hydroxy-acylcarnitines	 (Kurtz	 et	 al.,	
1998;	 Van	Vlies	 et	 al.,	 2005),	 and	 no	 accumulation	 of	 short-chain	
acylcarnitines. Trifunctional protein deficiency results in accumula-
tion	of	both	 long-chain	hydroxy-acylcarnitine	and	 long-chain	acyl-
carnitines, but there is no accumulation of short-chain acylcarnitines 
(Van	Hove	 et	 al.,	 2000).	 Importantly,	 in	 each	 discussed	 fatty	 acid	
oxidation	deficiency	disorder	 the	 level	of	acetylcarnitine	 is	not	 in-
creased,	 which	 agrees	 with	 reduced	 beta-oxidation	 (Ghosh	 et	 al.,	
2016).	Thus,	while	 short-chain	acylcarnitines	were	accumulated	 in	
CR,	the	profile	is	significantly	different	from	fat	oxidation	deficiency.
Increased acetyl-CoA suggests that production did not match 
consumption. Acetyl-CoA can be consumed through TCA cycle, 
ketone	 body	 production	 or	 exported	 from	mitochondria	 either	 as	
citrate or as acetylcarnitine. Other short-chain acyl-CoAs can also 
be	exported	as	cognate	carnitines.	We	do	not	know	 if	acetyl-CoA	
through TCA cycle was affected by CR. Blood ketones were induced, 
at	 least	at	ZT14,	 in	agreement	with	 increased	acetyl-CoA.	Protein	
acetylation in different cellular compartments was increased, impli-
cating	acetyl-CoA	export	from	the	mitochondria.	One	export	path-
way relies on the generation of acetylcarnitine by mitochondrial 
CrAT	and	export	via	the	carnitine	shuttle.	After	export	from	the	mi-
tochondria, acetylcarnitine is converted back to acetyl-CoA by cy-
toplasmic	CrAT	(Altamimi	et	al.,	2018;	Seiler	et	al.,	2015).	There	was	
a	 significant	 induction	 in	 the	 expression	of	CrAT	under	CR	 condi-
tions.	High	level	of	acetylcarnitine	and	increased	expression	of	CrAT	
suggest	that	the	carnitine	shuttle	pathway	of	export	was	induced	in	
CR.	Another	pathway	 for	 acetyl-CoA	export	 from	mitochondria	 is	
“citrate–malate–pyruvate	shuttle.”	It	is	known	that	citrate	transport	
plays an important role in fat biosynthesis when there is high carbo-
hydrate load. It is hypothesized that this pathway is reduced in fast-
ing	due	to	depletion	of	oxaloacetate	for	gluconeogenesis	(Pietrocola	
et	al.,	2015).	 It	 is	unknown	 if	 the	citrate	 shuttle	 is	affected	 in	CR.	
Therefore,	we	cannot	exclude	that	citrate	transport	contributes	to	
acetyl-CoA	export.	Finally,	it	was	suggested	that	increased	acetate	
is	responsible	for	increased	acetyl-CoA	in	CR	liver	(Sato	et	al.,	2017),	
but	it	was	not	experimentally	demonstrated.
What	might	 be	 a	 physiological	 significance	 for	 the	 increase	 of	
short-chain acyl-CoAs, acetyl-CoAs and corresponding acylcarni-
tines?	What	might	be	their	roles	in	CR	health	benefits?	Based	on	our	
data, we proposed a following model on CR-induced changes in fat 
oxidation	and	short-chain	acyl-CoA	homeostasis	and	how	 it	might	
impact	metabolism	and	physiology	(Figure	4d).
1. Acetyl-CoA and other short-chain acyl-CoAs can be used for 
protein	posttranslational	modifications.	Our	data	 expanded	 the	
results of several previous reports on CR and protein acetylation. 
CR	 induces	 protein	 acetylation	 in	 the	mitochondria	 (Schwer	 et	
al.,	2009),	while	 the	effect	might	be	protein	specific	 (Hebert	et	
al.,	2013),	and	total	(Sato	et	al.,	2017)	liver	extracts.	Our	results	
suggest that acetylation of cytoplasmic and nuclear proteins is 
also	 induced	 in	 the	 liver	 by	 CR	 (Figure	 4c).	 In	 agreement	 with	
our	 data,	 24-h	 fasting	 results	 in	 increased	 protein	 acetylation	
in the liver of wild-type mice but not in the liver of mice 
deficient	 for	 LCAD	 (Pougovkina	 et	 al.,	 2014).	 Thus,	 the	 ac-
tivity of long-chain acyl-CoA dehydrogenases is necessary for 
increased acetyl-CoA production during fasting and, probably, 
under CR, which needs to be tested in the future.
2. Fatty acids are natural ligands for transcriptional factors from the 
PPAR family, including PPARα and different ligands affect differ-
ent	subsets	of	targets	(Kersten	et	al.,	1999).	Here,	we	found	that	
CR	 differentially	 regulated	 the	 expression	 of	 several	 canonical	
PPARα	targets	(Mandard	et	al.,	2004)	in	the	liver.	Changes	in	the	
acyl profile induced by CR might modulate PPARα activity and 
contribute to changes in the transcriptional landscape under CR. 
It might also affect a crosstalk with other transcriptional regula-
tors, such as circadian clock transcriptional factors (Eckel-Mahan 
et	al.,	2013;	Mukherji	et	al.,	2015).
3. Finally, acylcarnitines can travel in the blood stream, and they 
can be released or consumed by tissues depending on energy 
demands.	 For	 example,	 skeletal	 muscles	 efflux	 acetylcarnitine	
at rest and uptake acetylcarnitine during the physical activity 
(Seiler	et	al.,	2015;	Simcox	et	al.,	2017).	Changes	in	acylcarnitine	
flux	might	contribute	to	metabolic	flexibility	of	the	tissues	during	
nutrient	 and	 energy	 stress	 (Muoio,	 2014).	 Therefore,	 under	CR	
conditions the liver may provide energy supply to other tissues in 
the form of short-chain acylcarnitines.
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4.	 Finally,	acetyl-CoA	and	other	short-chain	acyl-CoAs	may	also	act	
as signaling and regulatory molecules. High levels of short-chain 
acyl-CoAs are associated with reduced glycolysis and increased 
gluconeogenesis.	For	example,	pyruvate	dehydrogenase	activity	
is	suppressed,	and	pyruvate	carboxylase	activity	is	stimulated	by	
acetyl-CoAs, thus, redirecting pyruvate from TCA cycle to gluco-
neogenesis, which is important during prolonged fasting in CR.
Limitations of the study: acetyl-CoA is generated as a result of 
various	catabolic	processes.	While	our	data	 strongly	 implicate	 that	
beta-oxidation	is	the	main	contributor	to	the	increase	in	acetyl-CoA,	
it	needs	 to	be	directly	 tested.	Similarly,	 it	was	not	directly	assayed	
if	increased	butyryl-CoA	and	hexanoyl-CoA	were	produced	through	
the	oxidation	of	stored	triglycerides	or	from	gut	microbiota	derived	
short-chain fatty acids. Muscle and adipose tissue play an important 
role in whole body metabolism, but this study was limited to the liver. 
There is evidence that the outcome might be different in different tis-
sues. Indeed, CR increases protein acetylation in the liver mitochon-
dria,	but	in	several	other	tissues	the	effect	is	minimal	if	any	(Schwer	
et	al.,	2009).	Changes	in	protein	acetylation	may	be	due	to	changes	in	
the activities of protein deacetylases and acetylases, which were not 
assayed.	At	the	same	time,	it	is	expected	that	activities	of	deacety-
lases will be increased under CR, and activities of, at least some, 
acetylases will be decreased due to increased blood ketones.
4  |  E XPERIMENTAL PROCEDURE
Detailed	methods	and	list	of	reagents	are	available	in	Appendix	S1.
4.1  |  Animals
All	 experiments	 involving	 animals	 were	 conducted	 in	 accordance	
with	Federal	and	University	guidelines,	and	all	procedures	were	ap-
proved	by	IACUC,	Cleveland	State	University.	C57BL/6J	mice	were	
maintained	on	12	h	 light:	12	h	dark	cycle	 (LD12:12).	Mice	used	 in	
the	 experiments	were	12–13	weeks	of	 age	 at	 the	 start	 of	 the	 ex-
periments.	Animals	were	maintained	in	groups	of	three–four	animals	
per	cage	on	5008	LabDiet	(proteins	26.5%,	fat	16.9%,	carbohydrates	
56.5%).	CR	mice	received	food	once	per	day	2	h	after	the	lights	were	
turned	off	 (ZT14).	At	5	months	of	age,	 liver	tissues	were	collected	
across	the	day,	every	4	h	and	immediately	frozen	and	kept	at	−80°C	
for subsequent processing.
4.2  |  Blood Glucose and 
β-hydroxybutyrate detection
Blood for the analysis was collected through the tail vein at time 
points	 ZT2,	 6,	 10,	 14,	 18,	 and	 22.	 Blood	 ketones	were	measured	
as β-hydroxybutyrate	level	using	Precision	Xtra	Blood	Glucose	and	
Ketone	meter	(Abbott	Laboratories,	IL,	USA).
4.3  |  Analysis of mRNA expression
Total	RNA	was	extracted	from	frozen	liver	tissue	using	TRIzol	ac-
cording to manufacturer's instructions. After quantification and 
quality	check	of	total	RNA	by	electrophoresis,	total	RNA	was	re-
verse	transcribed	with	SuperScript	IV	Reverse	Transcriptase.	Real-
time	quantitative	PCR	was	performed	using	iTaq	Universal	SYBR	
Green	Supermix	(Bio-Rad).	18S	rRNA	expression	levels	were	used	
for normalization. Fold change was determined by ΔΔCt method.
4.4  |  Analysis of protein expression
Total liver lysates were prepared with lysis buffer (1 M Tris Base pH 
7.5,	5	M	NaCl,	0.5	M	EGTA,	0.5	M	EDTA,	Triton-X,	0.1	M	Na4P2O7, 
1 M β-glycerophosphate,	 1	 M	 Na3VO4)	 containing	 protease	 and	
phosphatase	inhibitor	cocktails	(Sigma).	For	fractionated	protein	ex-
tracts, 30 mg of liver was homogenized with Dounce homogenizer 
in	Buffer	A	 (10	mM	HEPES,	 1.5	mM	MgCl2,	 10	mM	KCl,	 0.5	mM	
DTT,	0.05%	NP40,	0.1	M	Na4P2O7,	1	M	β-glycerophosphate, 1 M 
Na3VO4,	and	protease	and	phosphatase	inhibitor	cocktails)	and	cen-
trifugated	at	 rcf:	960	g	 for	5	min	at	4°C.	The	pellet	contained	the	
nuclear fraction, and supernatant was centrifugated at rcf: 6800 g 
for	 5	min	 for	 separation	 of	 cytosolic	 (supernatant)	 and	mitochon-
dria	 (pellet)	 fractions.	 After	 SDS-PAGE,	 proteins	were	 transferred	
onto	PVDF	membrane.	For	list	of	antibodies,	see	Supplemental	Key	
Resources	 Table.	 Quantification	 of	 images	 was	 done	 using	 Image	
Studio	Lite	software.
4.5  |  Sample Preparation for Acylcarnitine and 
acyl-CoA Analysis
Internal standard stock solutions were prepared as follows: 
Acylcarnitine	Internal	Standard	Mix	(1520	nM	d9-carnitine,	380	nM	
d3-acetylcarnitine,	76	nM	d3-propionylcarnitine,	76	nM	d3-butyryl-
carnitine,	 76	 nM	 d9-isovalerylcarnitine,	 76	 nM	 d3-octanoylcarni-
tine,	 76	 nM	 d9-myristoylcarnitine,	 152	 nM	 d3-palmitoylcarnitine)	
in methanol. 13C2-acetyl-CoA	(1000	ng/ml	in	1:1	v/v	methanol:5%	
acetic	acid).
All sample preparations were performed on ice. Mouse liver 
tissues	 (~40	mg	 frozen	mass	 stored	 at	 −80°C)	were	 spiked	with	
10	 µl	 of	 NSK-B	 acylcarnitine	 internal	 standard	 mix	 (Cambridge	
Isotope	 Labs)	 and	 10	 µl	 of	 1000	 ng/ml	 13C2-acetyl-CoA	 (Sigma	
Aldrich).	 Each	 tissue	 was	 homogenized	 in	 1	 ml	 of	 “Extraction	
Matrix”	(1:1	v/v)	methanol:5%	acetic	acid	(aq)	using	a	VWR	pellet	
mixer	and	centrifuged	at	12	k	rpm	for	5	min.	The	supernatant	was	
transferred to a 13 mm glass tube. The remaining tissue was ho-
mogenized	and	centrifuged	again	in	1	ml	of	Extraction	Matrix.	The	
combined	supernatants	were	dried	under	N2 and reconstituted in 
200	µl	of	Extraction	Matrix.	A	total	of	50	µl	was	aliquoted	for	acyl-
carnitine	analysis,	and	the	remaining	kept	at	−80°C	for	acyl-CoA	
analysis.	The	50	µl	aliquot	was	dried	under	N2 and derivatized by 
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addition	of	60	µl	butanol-1-HCl	(Sigma	Aldrich)	incubated	at	80°C	
for	20	min.	The	sample	was	dried	under	N2 and reconstituted in 
60	µl	of	(80:20:0.1	v/v/v)	acetonitrile:water:formic	acid.	The	sam-
ples	were	stored	at	−80°C.	For	analysis,	frozen	samples	were	kept	
on ice and transferred to HPLC vials with 100 µl glass inserts after 
vortex	mixing.
4.6  |  Acylcarnitine Analysis by LC-MS/MS
Analysis	was	performed	using	a	Shimadzu	Nexera	UHPLC	coupled	
to	a	SCIEX	QTrap	5500	mass	spectrometer.	The	SCIEX	Turbo	V	ESI	
source	was	operated	in	positive	mode	with	curtain	gas	set	to	40	
psi,	CAD	gas	set	to	high,	 IS	voltage	4500	V,	temperature	700°C,	
GS1	and	GS2	gases	at	50	psi	and	45	psi,	respectively.	Compound-
specific parameters were optimized by direct infusion of a 1 µM 
mixture	of	butylated	free	carnitine,	acetylcarnitine,	butyrylcarni-
tine,	octanoylcarnitine,	and	palmitoylcarnitine	in	0.1%	formic	acid	
in acetonitrile. Butylated acylcarnitines fragment similarly produc-
ing	a	common	fragment	m/z	85	 in	positive	mode.	Therefore,	 the	
MRM transitions for acylcarnitines of interest were measured by 
monitoring	 the	parent	 ion	 [M	+	H]+	>	m/z	85.1,2	 Separation	was	
achieved	using	a	Waters	XBridge	BEH	C18	(75	×	2.1	mm,	2.5	μm)	
column	heated	to	40°C	with	flow	rate	0.6	ml/min.	The	autosam-
pler	was	kept	at	4°C	and	sample	injection	volume	set	to	1	µl.	The	
needle	was	rinsed	externally	after	each	injection	with	acetonitrile.	
Gradient	 elution:	 0.1%	 formic	 acid	 in	HPLC-grade	water	 (mobile	
phase	 A)	 and	 0.1%	 formic	 acid	 in	 acetonitrile	 (mobile	 phase	 B).	
Time	program:	1	min	hold	at	20%	B,	 linear	 increase	 to	37%	B	at	
8	min,	and	linear	increase	to	100%	B	at	22	min.	Hold	at	100%	B	for	
4	min	followed	by	re-equilibration	at	starting	conditions	for	4	min.	
Total run time was 30 min per sample.
4.7  |  Acyl-CoA Analysis by LC-MS/MS
Analysis	was	performed	using	a	Shimadzu	Nexera	UHPLC	coupled	
to	 a	 SCIEX	QTrap	5500	mass	 spectrometer.	 The	 SCIEX	Turbo	V	
ESI	 source	 was	 operated	 in	 positive	 mode	 with	 curtain	 gas	 set	
to	30	psi,	CAD	gas	 set	 to	medium,	 IS	 voltage	5000	V,	 tempera-
ture	 550°C,	 GS1	 and	 GS2	 gases	 at	 40	 psi.	 Compound-specific	
parameters were optimized by direct infusion of a 1000 ng/ml 
mixture	 of	 free	 CoA,	 acetyl-CoA,	 succinyl-CoA,	 glutaryl-CoA,	
acetoacetyl-CoA, propionyl-CoA, octanoyl-CoA, palmitoyl-CoA, 
octadecenoyl-CoA,	 and	 3-hydroxybutyryl-CoA.	 Acyl-CoAs	 pro-
duce	 the	 common	 fragment	m/z	 507.	 The	 acyl-CoAs	 of	 interest	
were detected by monitoring the MRM transition of parent ion 
[M + H]+ to the appropriate fragment ion produced by the loss of 
m/z	507.3,4	Separation	was	achieved	using	a	Waters	Acquity	CSH	
C18	(50	×	2.1	mm,	1.7	μm)	column	heated	to	30°C	with	flow	rate	
0.6	ml/min.	The	autosampler	was	kept	at	4°C	and	sample	injection	
volume	 set	 to	5	µl.	 The	needle	was	 rinsed	 externally	 after	 each	
injection	with	 (3:2:1:0.2	v/v/v/v)	acetonitrile:isopropanol:water:p
hosphoric acid. Gradient elution: 100 mM ammonium formate in 
98:2	v/v	water:acetonitrile	(mobile	phase	A)	and	5	mM	ammonium	
formate	in	95:5	v/v	acetonitrile:water.	(mobile	phase	B).	Time	pro-
gram:	1	min	hold	at	2.5%	B,	linear	increase	to	55%	B	at	4	min,	and	
linear	increase	to	98%	B	at	6	min.	Hold	at	98%	B	for	2	min	followed	
by	re-equilibration	at	starting	conditions	for	7	min.	Total	run	time	
was	15	min	per	sample.
4.8  |  Quantification and Statistical Analysis
Data	for	both	diets	were	analyzed	using	ordinary	two-way	ANOVA	
(multiple comparison correction was done using the Bonferroni 
method).	 All	 statistical	 analysis	 was	 performed	 using	 GraphPad	
Prism	 7.0	 (San	 Diego,	 CA).	 Rhythms	 analysis	 was	 performed	 in	
R-studio	using	MetaCycle	package	(Wu	et	al.,	2016).	At	least	three	
biological replicates have been used for every time point and every 
diet.	Exact	number	of	biological	samples	for	every	experiment	is	re-
ported	in	the	Figure	legends.	Data	are	shown	as	Mean	±	SD.	p	≤	0.05	
was considered as statistically significant difference.
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